News

RECENT NEWS

The FDA has approved VYKAT™ XR (diazoxide choline extended-release tablets) as the first-ever treatment for hyperphagia in individuals with Prader-Willi syndrome. This groundbreaking approval marks a major step forward for the PWS community, made possible by years of advocacy from families, researchers, and PWSA | USA.

Soleno Therapeutics, the company behind the treatment, will host a Caregiver Now Approved Webinar on April 16th to share more details.

Learn how you can help amplify this historic moment and support awareness efforts.

Get in Touch

Learn More about PWSA | USA

Are you a journalist or media partner? Download everything you need here.

Press Enquiries

Have a story to share or media inquiry? Reach out directly to the right member of our team using the contacts below.

General Press Inquiries
– Stacy Ward – sward@pwsausa.org

Research & Advocacy
– Dorothea Lantz – dlantz@pwsausa.org

Marketing & Communications
– Carolyn Larsen – clarsen@pwsausa.org
– Anne Fricke – africke@pwsausa.org